SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

SERINO, Maria Luisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.519
AS - Asia 4.614
EU - Europa 3.118
SA - Sud America 746
Continente sconosciuto - Info sul continente non disponibili 156
AF - Africa 112
OC - Oceania 10
Totale 17.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.265
SG - Singapore 1.780
CN - Cina 1.112
IT - Italia 1.003
BR - Brasile 584
VN - Vietnam 506
DE - Germania 458
UA - Ucraina 364
HK - Hong Kong 336
TR - Turchia 283
GB - Regno Unito 247
PL - Polonia 218
FI - Finlandia 185
FR - Francia 149
CA - Canada 134
BD - Bangladesh 120
JP - Giappone 120
SE - Svezia 120
RU - Federazione Russa 92
IN - India 89
MX - Messico 83
AR - Argentina 62
ID - Indonesia 59
NL - Olanda 52
SM - San Marino 49
ZA - Sudafrica 46
ES - Italia 42
EC - Ecuador 34
IQ - Iraq 29
BE - Belgio 26
PK - Pakistan 26
CZ - Repubblica Ceca 24
VE - Venezuela 22
LT - Lituania 20
CO - Colombia 15
MA - Marocco 14
AT - Austria 13
EG - Egitto 13
UZ - Uzbekistan 12
LK - Sri Lanka 11
SA - Arabia Saudita 11
MY - Malesia 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
IE - Irlanda 9
IR - Iran 9
KE - Kenya 9
PH - Filippine 9
AU - Australia 8
CR - Costa Rica 8
AZ - Azerbaigian 7
IL - Israele 7
JM - Giamaica 7
KZ - Kazakistan 7
NP - Nepal 7
TH - Thailandia 7
CH - Svizzera 6
DO - Repubblica Dominicana 6
GR - Grecia 6
JO - Giordania 6
TN - Tunisia 6
TW - Taiwan 6
AL - Albania 5
BG - Bulgaria 5
DK - Danimarca 5
KR - Corea 5
PS - Palestinian Territory 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DZ - Algeria 4
EU - Europa 4
HR - Croazia 4
NO - Norvegia 4
PE - Perù 4
RO - Romania 4
BH - Bahrain 3
BO - Bolivia 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BF - Burkina Faso 2
CG - Congo 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
Totale 17.109
Salva come PNG Salva come JPEG
Città #
Singapore 1.023
Ashburn 901
Woodbridge 658
San Jose 564
Fairfield 537
Chandler 484
Jacksonville 408
Beijing 390
Santa Clara 378
Hong Kong 332
Houston 306
Ann Arbor 261
Council Bluffs 246
Seattle 241
Wilmington 224
Warsaw 212
New York 192
Los Angeles 165
Cambridge 158
Ho Chi Minh City 151
Izmir 151
Dallas 137
Ferrara 135
Munich 128
Milan 119
Tokyo 118
Hanoi 115
Nanjing 112
Princeton 87
Lauterbourg 81
Boardman 73
Orem 73
Helsinki 66
Shanghai 60
Mexico City 53
São Paulo 50
Toronto 50
Buffalo 48
London 48
San Diego 47
Rome 42
The Dalles 42
Chicago 41
Turku 41
Montreal 40
Bremen 38
Phoenix 38
Jakarta 35
Denver 34
Shenyang 34
Brooklyn 32
Dearborn 32
Chennai 31
Hebei 30
Johannesburg 29
Naples 27
Frankfurt am Main 26
Nanchang 26
Rio de Janeiro 25
Brussels 24
Da Nang 24
Haiphong 24
Boston 23
Changsha 23
San Francisco 23
Amsterdam 22
Atlanta 20
Bologna 20
Jiaxing 20
Redwood City 20
Stockholm 20
Düsseldorf 19
Manchester 19
Tianjin 18
Nuremberg 16
Curitiba 15
Hefei 15
Hải Dương 15
Jinan 15
Mountain View 15
Poplar 15
Charlotte 14
Moscow 14
Brasília 13
Brno 13
Falls Church 13
Guangzhou 13
Washington 13
Baghdad 12
Des Moines 12
Dong Ket 12
Guayaquil 12
Jackson 12
Bắc Ninh 11
Domagnano 11
Meda 11
Ottawa 11
Tashkent 11
Augusta 10
Colombo 10
Totale 10.878
Salva come PNG Salva come JPEG
Nome #
ProC Global test>ProC Complete test: una modificazione del Global test per la misurazione contemporanea della attività della PC, della PS, e del fenotipo Leiden. 593
Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in Cognitive Impairment Diseases 496
Inherited genetic predispositions in F13A1 and F13B genes predict abdominal adhesion formation: identification of gender prognostic indicators 296
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 288
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 280
Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration 276
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 273
COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? 269
Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells 269
F13A1 gene variant (V34L) and residual circulating FXIIIA levels predict short-and long-term mortality in acute myocardial infarction after coronary angioplasty 261
Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension 260
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 255
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 250
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 249
A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases 244
Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories 243
Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients 240
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 239
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 231
Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults 230
Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis 229
A photometric assay for factor-XIII in chronic hepatopathies. 227
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 226
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 220
A modified functional Global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. 216
A photometric method for the dosage of factor XIII applied to the study of chronic hepatopathies. 204
A web-based clinical record 'xl'Emofilia® 'for outpatients with haemophilia and allied disorders in the region of Emilia-Romagna: Features and pilot use 200
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 198
C677T Substitution in the Methylenetetrahydrofolate Reductase Gene as a Risk Factor for Venous Thrombosis and Arterial Disease in Selected Patients. 198
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 196
Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation 194
The reduced sensitivity of the ProC (R) Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk 193
A de novo antithrombin mutation found in a patient with deep vein thrombosis and vascular abnormalities 190
Different anticoagulant response to activated protein C (APC test) and to Agkistrodon Contortix venom (ACV test) in a family with FV-R506Q substitution 189
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 189
Cancers in patients with hemophilia: a retrospective study from the Italian Association of Hemophilia Centers 189
A modified functional global test to measure PC, PS activities and the APC-resistance phenotype 186
Low folate levels and thermolabile methylenetetrahydrofolate reductase as primary determinant of mild hyperhomocystinemia in normal and thromboembolic subjects 186
Maternal Haplotypes in DHFR Promoter and MTHFR Gene in Tuning Childhood Acute Lymphoblastic Leukemia Onset-Latency: Genetic/Epigenetic Mother/Child Dyad Study (GEMCDS) 184
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 183
Common Gene Polymorphisms in the Metabolic Folate and Methylation Pathway and the Risk of Acute Lymphoblastic Leukemia and non-Hodgkin’s Lymphoma 181
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 181
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocytic Leukemia in Adults 181
Common Polymorphisms in the Metabolic Folate Pathway Decrease the Risk of Acute Lymphocitic Leukemia in Adults 179
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 179
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 179
Una "rete" per proteggere il cuore. (FAR 2013) 178
Clinical observations on the relationship between idiopathic thrombocytopenic purpura lupus anticoagulant and anticardio-lipin antibody syndrome. 176
Factor XIIIA-V34L and Factor XIIIB-H95R Gene Variants and Survival after Myocardial Infarction. 174
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 172
Malattie emorragiche vascolari. 169
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy 167
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: Identification of 23 new mutations 165
Epigenetic role of LINE-1 methylation and key genes in pregnancy maintenance 164
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 161
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 160
Mortality and causes of death in Italian persons with haemophilia, 1990-2007 159
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 158
Gene Dosage of F5 c.3481C>T Stop-Codon (p.R1161Ter) Switches the Clinical Phenotype from Severe Thrombosis to Recurrent Haemorrhage: Novel Hypotheses for Readthrough Strategy 157
A Common mutation in the gene for coagulation factor XIII-A (V34L): a risk factor for hemorrhagic disorders it is protective against atherothrombotic diseases. 157
Anticardiolipin antibody-related thrombocytopenia: persistent remission after splenectomy. 153
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 151
Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes 147
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 147
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 147
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 146
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 145
Thrombotic risk in thalassemic patients 144
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 143
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 142
Bassi livelli di Proteina S e Resistenza alla Proteina C attivata in dieci famiglie italiane. 137
DHFR 19-bp insertion/deletion polymorphism and MTHFR C677T in adult acute lymphoblastic leukaemia: is the risk reduction due to intracellular folate unbalancing? 135
High protein C plasma levels affect the response to exogenous preactivated protein C and enhance that to endogenous Protac-mediated activated protein C. 128
Favourable recombinant factor IX pharmacokinetics outcomes in severe hemophilia B patients with FIX activation site mutations 128
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 124
Genotype and PK Hemophilia B International Study (GePKHIS) - A progress Report 124
MTHFR Specific Activity, Homocysteine and Folate Levels in Subjects with Thermolabile MTHFR (C677T) 122
null 118
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 111
FXIII-A V34L and FXIII-B H95R gene polymorphism: effects on the efficacy of thrombolytic therapy in acute myocardial infarction. 109
miRNAs Epigenetic Tuning of Wall Remodeling in the Early Phase after Myocardial Infarction: A Novel Epidrug Approach 103
null 102
Detection of a Protein C Gene Mutation Present in the Asymptomatic and not in the Thrombosis-Prone Lineage. 101
Treatment outcome and postoperative complications of mucogingival surgery in a case of type I von Willebrand disease 99
Piastrinopenia da anticorpi anticardiolipina: remissione persistente dopo splenectomia. 93
Common Factor XIII Gene Polymorphisms In Venous Leg Ulcers. 93
Conteggio piastrinico e terapia sostitutiva in un paziente con Malattia di von Willebrand tipo 2B. 92
null 91
Sui rapporti tra anticorpi anticardiolipina e ß-2-glicoproteina I plasmatica. 89
null 85
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 80
null 80
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 77
GRB 130427A: a Nearby Ordinary Monster 74
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 69
null 61
null 49
Totale 17.275
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 634
Totale 72.499
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 0 0 46 41 65 36 37 51 28 86 104 236
2022/20231.093 106 104 21 131 189 156 60 109 111 9 63 34
2023/2024605 53 69 26 26 72 94 28 49 9 21 25 133
2024/20252.456 72 45 175 91 312 188 97 122 467 256 353 278
2025/20266.604 633 262 536 882 945 445 684 340 592 651 443 191
2026/2027697 180 339 178 0 0 0 0 0 0 0 0 0
Totale 17.275